Interactions between the ADORA2b/Sphk1axis and the AE1-Hb switch in red blood cell aging in vivo and in vitro

ADORA2b/Sphk1axis 和 AE1-Hb 开关在体内和体外红细胞老化中的相互作用

基本信息

  • 批准号:
    10580716
  • 负责人:
  • 金额:
    $ 63.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-03-15 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

ABSTRACT Red Blood Cells (RBCs) represent ~83% of the total human cells in the body. RBC hemoglobin (Hb), which is critical for their function to carry and deliver oxygen to peripheral tissues, constitutes ~90% of the total protein content of a mature RBCs. During their lifespan of 120 days in the bloodstream, RBCs are constantly exposed to oxidant stress, which mostly arises from Fenton and Haber-Weiss reactions triggered by Hb-Iron in the presence of oxygen. However, RBCs lack nuclei and organelle and, as such, they cannot synthesize new proteins to replace oxidatively damaged components. Therefore, in order to cope with oxidant stress, RBCs have evolved unique mechanisms that rely on signaling axes and their capacity to trigger metabolic reprogramming to favor antioxidant defenses (the Pentose Phosphate Pathway – PPP) over energy metabolism (glycolysis). One such mechanism relies on the two most abundant proteins in RBC cytosols and membranes: Hb and anion exchanger 1 (AE1), respectively. Owing to its capacity to “sense” oxygen, in response to hypoxia, deoxygenated Hb migrates to the membrane, where it binds the N-terminus of AE1. This mechanism releases a series of glycolytic enzymes, which are inhibited under high-oxygen tensions owing to their binding to the same region of AE1 with high affinity for deoxygenated Hb. This phenomenon favors energy metabolism under low oxygen tensions (e.g., high-altitude hypoxia), while it creates a metabolic bottleneck in energy metabolism to promote a critical antioxidant pathway when oxidant stress is high: the Pentose Phosphate Pathway (PPP). This mechanism is referred to as the AE1-Hb switch in this proposal. Of note, glucose 6-phosphate dehydrogenase (G6PD) is not only the rate-limiting enzyme of the PPP, but also the target of the most common enzymopathy in humans, G6PD deficiency, which affects ~400 million people. While RBCs from G6PD-deficient subjects are perfectly healthy in the absence of oxidant stress, RBCs from these individuals are characterized by a shorter lifespan and susceptibility to lysis following oxidative insults. Oxidative stress to RBCs is not only relevant within the context of RBC senescence. Significant oxidant stress arises during RBC storage under blood bank conditions for blood transfusion purposes, a common in hospital medical procedure and a life-saving intervention for ~3-4 million Americans every year. However, little is known about the impact of the AE1-Hb switch and G6PD deficiency in the context of RBC aging in vitro (blood bank). In parallel, when studying human acclimatization to high-altitude hypoxia, we discovered a novel axis, the ADORA2b/Sphk1 axis, that interplays with the AE1-Hb switch to favor oxygen off-loading in healthy individuals as they climb to high-altitude, where oxygen is limited in comparison to sea level. By leveraging a combination of state-of-the art omics technologies (fluxomics and Xlinking proteomics) and a mix of well-established and novel animal models (exclusively developed for this proposal – e.g., G6PD-def mice) we will investigate the interplay of the AE1-Hb switch and ADORA2b/Sphk1 in the context of oxidant stress and hypoxia during RBC aging in vivo (senescence) and in vitro (blood bank).
摘要 红细胞(RBC)占人体总细胞的约83%。RBC血红蛋白(Hb), 对于它们携带氧气并将氧气输送到外周组织的功能至关重要,占总蛋白质的约90 成熟红细胞的含量。在血液中120天的生命周期中,红细胞不断暴露于 氧化应激,这主要是由于芬顿和Haber-Weiss反应引发的Hb-铁在 氧气的存在。然而,红细胞缺乏细胞核和细胞器,因此,它们不能合成新的 蛋白质,以取代氧化损伤的成分。因此,为了科普氧化应激,红细胞 进化出了依赖于信号轴的独特机制及其触发代谢重编程的能力 有利于抗氧化防御(戊糖磷酸途径- PPP)超过能量代谢(糖酵解)。 其中一种机制依赖于红细胞胞浆和膜中最丰富的两种蛋白质:血红蛋白和阴离子 交换器1(AE 1)。由于其能够“感知”氧气,在缺氧时, Hb迁移到膜上,在那里它结合AE 1的N-末端。这种机制释放出一系列 糖酵解酶,这是抑制下高氧张力,由于它们的结合相同的区域, AE 1对脱氧血红蛋白具有高亲和力。这种现象有利于低氧条件下的能量代谢 张力(例如,高海拔缺氧),同时它在能量代谢中产生代谢瓶颈,以促进 氧化应激高时的关键抗氧化途径:磷酸戊糖途径(PPP)。这 该机制在本建议中被称为AE 1-Hb开关。值得注意的是,葡萄糖6-磷酸脱氢酶 葡萄糖-6-磷酸脱氢酶(G6 PD)不仅是PPP的限速酶,也是PPP最常见的酶病的靶标, G6 PD缺乏症,影响约4亿人。虽然来自G6 PD缺陷受试者的RBC 在没有氧化应激的情况下完全健康,来自这些个体的RBC的特征在于较短的 寿命和氧化损伤后对溶解的敏感性。红细胞的氧化应激不仅与 RBC衰老的背景。在血库下储存红细胞期间出现显著的氧化应激 输血的条件,一种常见的医院医疗程序和挽救生命的干预措施 每年约有3-4百万美国人。然而,关于AE 1-Hb开关和G6 PD的影响知之甚少。 在体外RBC老化的背景下缺乏(血库)。与此同时,当研究人类对 在高原缺氧中,我们发现了一个新的轴,ADORA 2b/Sphk 1轴,它与AE 1-Hb相互作用, 当健康人爬到高海拔时,他们会转向有利于氧气的卸载,因为那里的氧气是有限的。 与海平面相比。通过利用最先进的组学技术(通量组学和 Xlinking蛋白质组学)和成熟的新型动物模型(专门为此开发)的混合 建议-例如,G6 PD-def小鼠),我们将研究AE 1-Hb开关和ADORA 2b/Sphk 1的相互作用, RBC在体内(衰老)和体外(血库)老化过程中氧化应激和缺氧的背景。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Angelo D'Alessandro其他文献

Angelo D'Alessandro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Angelo D'Alessandro', 18)}}的其他基金

Investigating metabolic responses to high sugar diets and the onset of diabetic phenotypes
研究对高糖饮食的代谢反应和糖尿病表型的发生
  • 批准号:
    10719544
  • 财政年份:
    2023
  • 资助金额:
    $ 63.65万
  • 项目类别:
Interactions between the ADORA2b/Sphk1axis and the AE1-Hb switch in red blood cell aging in vivo and in vitro
ADORA2b/Sphk1axis 和 AE1-Hb 开关在体内和体外红细胞老化中的相互作用
  • 批准号:
    10369002
  • 财政年份:
    2020
  • 资助金额:
    $ 63.65万
  • 项目类别:
The Impact of Oxidative Stress on Erythocyte Biology
氧化应激对红细胞生物学的影响
  • 批准号:
    10252033
  • 财政年份:
    2019
  • 资助金额:
    $ 63.65万
  • 项目类别:
The Impact of Oxidative Stress on Erythocyte Biology
氧化应激对红细胞生物学的影响
  • 批准号:
    10487440
  • 财政年份:
    2019
  • 资助金额:
    $ 63.65万
  • 项目类别:
PIMT1 in Red Blood Cell aging in vivo and in vitro
PIMT1在体内和体外红细胞老化中的作用
  • 批准号:
    10405591
  • 财政年份:
    2019
  • 资助金额:
    $ 63.65万
  • 项目类别:
PIMT1 in Red Blood Cell aging in vivo and in vitro
PIMT1在体内和体外红细胞老化中的作用
  • 批准号:
    10605316
  • 财政年份:
    2019
  • 资助金额:
    $ 63.65万
  • 项目类别:
PIMT1 in Red Blood Cell aging in vivo and in vitro
PIMT1在体内和体外红细胞老化中的作用
  • 批准号:
    9983156
  • 财政年份:
    2019
  • 资助金额:
    $ 63.65万
  • 项目类别:
The Impact of Oxidative Stress on Erythocyte Biology
氧化应激对红细胞生物学的影响
  • 批准号:
    10022515
  • 财政年份:
    2019
  • 资助金额:
    $ 63.65万
  • 项目类别:

相似国自然基金

细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
  • 批准号:
    81570244
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
  • 批准号:
    81171113
  • 批准年份:
    2011
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目

相似海外基金

Studies on the role of adenosine A2B receptor in visceral hypersensitivity
腺苷A2B受体在内脏过敏中作用的研究
  • 批准号:
    18K15033
  • 财政年份:
    2018
  • 资助金额:
    $ 63.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Are pulmonary GABA-receptors the key for the therapy of acute pulmonary inflammation and does the link with the adenosine A2B-receptor represent the first step towards personalized medicine?
肺部 GABA 受体是治疗急性肺部炎症的关键吗?与腺苷 A2B 受体的联系是否代表着个体化医疗的第一步?
  • 批准号:
    398748271
  • 财政年份:
    2018
  • 资助金额:
    $ 63.65万
  • 项目类别:
    Research Grants
Adenosine A2B Receptor in Bone Health and Osteoporosis
腺苷 A2B 受体在骨骼健康和骨质疏松症中的作用
  • 批准号:
    9551206
  • 财政年份:
    2017
  • 资助金额:
    $ 63.65万
  • 项目类别:
Characterization of intestinal adenosine A2b receptor
肠腺苷 A2b 受体的表征
  • 批准号:
    6669814
  • 财政年份:
    2003
  • 资助金额:
    $ 63.65万
  • 项目类别:
Characterization of intestinal adenosine A2b receptor
肠腺苷 A2b 受体的表征
  • 批准号:
    6802024
  • 财政年份:
    2003
  • 资助金额:
    $ 63.65万
  • 项目类别:
INTESTINAL ADENOSINE A2B RECEPTOR
肠腺苷 A2B 受体
  • 批准号:
    6032483
  • 财政年份:
    2000
  • 资助金额:
    $ 63.65万
  • 项目类别:
INTESTINAL ADENOSINE A2B RECEPTOR
肠腺苷 A2B 受体
  • 批准号:
    6524096
  • 财政年份:
    2000
  • 资助金额:
    $ 63.65万
  • 项目类别:
INTESTINAL ADENOSINE A2B RECEPTOR
肠腺苷 A2B 受体
  • 批准号:
    6643364
  • 财政年份:
    2000
  • 资助金额:
    $ 63.65万
  • 项目类别:
INTESTINAL ADENOSINE A2B RECEPTOR
肠腺苷 A2B 受体
  • 批准号:
    6700597
  • 财政年份:
    2000
  • 资助金额:
    $ 63.65万
  • 项目类别:
INTESTINAL ADENOSINE A2B RECEPTOR
肠腺苷 A2B 受体
  • 批准号:
    6380167
  • 财政年份:
    2000
  • 资助金额:
    $ 63.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了